Biotech Breakthroughs in 2024 and the 3 Stocks That Can Benefit

Source: everything possible / Shutterstock.com After being mostly down over the past three years, the biotech sector rallied hard to end 2023. The SPDR S&P Biotech ETF (NYSEARCA:XBI) is up 31% in the last three months. From 2010 through 2019, investing in the XBI was a good proxy for the biotech sector. However, the monetary...

You are unauthorized to view this page.

Facebook
Twitter
LinkedIn
WhatsApp
Email